Terbinafine monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Liver function testing before or during treatment according to local practice
Oral terbinafine can rarely cause hepatotoxicity, so liver function assessment is commonly arranged before and sometimes during treatment. Patients should report symptoms such as unexplained nausea, anorexia, dark urine, pale stools or jaundice. Topical treatments may be considered where oral therapy is unsuitable.
Reference: BNF; NICE CKS